Enhanced Bioactivity of a Human GHR Antagonist Generated by Solid-Phase Site-Specific PEGylation.

Wang, Yue; Langley, Ries J; Tamshen, Kyle; Harms, Julia; Middleditch, Martin J; Maynard, Heather D; Jamieson, Stephen M F; Perry, Jo K

Wang, Yue; Langley, Ries J; Tamshen, Kyle; Harms, Julia; Middleditch, Martin J; Maynard, Heather D; Jamieson, Stephen M F; Perry, Jo K.

Afiliación

Wang Y; Liggins Institute, University of Auckland, Auckland 1023, New Zealand.
Langley RJ; Department of Molecular Medicine and Pathology, University of Auckland, Auckland 1023, New Zealand.
Tamshen K; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1023, New Zealand.
Harms J; Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles 90095-1569, California, United States.
Middleditch MJ; Liggins Institute, University of Auckland, Auckland 1023, New Zealand.
Maynard HD; Auckland Cancer Society Research Centre, University of Auckland, Auckland 1023, New Zealand.
Jamieson SMF; School of Biological Sciences, University of Auckland, Auckland 1023, New Zealand.
Perry JK; Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles 90095-1569, California, United States.

Biomacromolecules ; 22(2): 299-308, 2021 02 08.

Article en En | MEDLINE | ID: mdl-33295758

Asunto(s)

Cisteína; Hormona del Crecimiento; Animales; Dimerización; Escherichia coli; Humanos; Ratones; Proteínas Recombinantes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hormona del Crecimiento / Cisteína Límite: Animals / Humans Idioma: En Revista: Biomacromolecules Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google